Table 4.
Parameters | r (p-value) |
---|---|
BASDAI and ASDAS | 0.635 (p=0.01) |
BASFI and homocysteine | 0.738 (p=0.037) |
BASFI and BMI | 0.556 (p<0.01) |
RF-QIMT and sRI (L): | 0.482 (p=0.037) |
RF-QIMT and Framingham score | 0.537 (p=0.012) |
Expected QIMT and Framingham score | 0.915 (p<0.01) |
sRI (R) and ESR | 0.506 (p=0.027) |
sRI (R) and cRI (R) | 0.816 (p<0.01) |
cRI (R) and cRI (L) | 0.847 (p<0.01) |
AsGs (L) and AsGs (R) | 0.733 (p<0.01) |
AsGs (L) and abdominal waist measurement | 0.381 (p=0.044) |
AsGs (L) and BMI | 0.459 (p=0.032) |
TGS (L) and TGS (R) | 0.518 (p=0.016) |
ASDAS, ankylosing spondylitis activity score; AsGs, sacral area measurement; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; BMI, body mass index; cRI, carotid RI; ESR, erythrocyte sedimentation rate; L, left; QIMT, quality intima-media thickness; R, right; RF, radiofrequency; RI, resistive index (decrease); sRI, sacroiliac RI; TGS, Achilles tendon measurement.